Filter by
 

Type of content

Publication date

Main subject

Main subject

Keywords

Keywords

Target audience

Series/ Type

Series/type

Search tool

Displaying 1 - 20 of 70

Publications

EMCDDA corporate identity and logo toolkit

24.09.2021

This toolbox provides guidelines and downloadable resources related to the EMCDDA logo.

Publications

Final EMCDDA annual accounts for the financial year 2020

08.07.2021

These accounts have been drawn up and signed off by the Accounting Officer on 31 May 2021 and approved by the Director on 1 June 2021. The opinion of the Management Board was given favourably on 24 June 2021. The present annual accounts, together with the opinion of the Management Board, have been...

Publications

General Report of Activities 2020 – key achievements and governance: a year in review

15.06.2021

The General Report of Activities is an annual publication providing a detailed progress report of the EMCDDA’s activities over a 12-month period. It catalogues the Centre’s achievements in each area of its annual work programme. The report is a useful information source for all those seeking...

Publications

European Drug Report 2021: Trends and Developments

09.06.2021

The Trends and Developments report presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm reduction interventions.

Publications

Reitox Development Framework - Roadmap 2025

16.05.2021

During the year 2021 new roadmaps were defined for the agency’s Strategy 2025 and for its accompanying document, the Reitox Development Framework (RDF). These two roadmaps describe the activities and milestones to be implemented to reach the strategic and specific objectives set out in the longer-...

Publications

Reitox Development Framework Roadmap 2020 - Evaluation of the implementation

16.05.2021

In 2017, when the Reitox Development Framework (RDF) was prepared and adopted, one of the key issues underlined by the Centre and the network alike was the need to ensure its execution through the definition of concrete implementing activities; and that the implementation of those activities would...

Publications

Single programming document 2021–2023

12.02.2021

The new Single programming document sets out the EMCDDA’s activities for the period 2021–2023, marking the start of a new five-year roadmap under Strategy 2025. At the heart of the agency’s work in 2021 will be the development of a new business model, which places customers and digital...

Publications

EMCDDA certification of the Reitox national focal points

15.12.2020

This document describes the EMCDDA's Reitox certification process. The Reitox certification project is a process for formal acknowledgement of the competence of an EMCDDA national focal point to carry out specific tasks in a reliable, credible and accurate manner and confirmation that it meets the...

Publications

Protocol for updating the Evidence database of the Best Practice Portal

14.12.2020

The Evidence database is a core component of the EMCDDA’s Best Practice Portal. The portal is a resource for professionals, policymakers and researchers in the drugs field and provides information on the available evidence on drug-related prevention, treatment and harm reduction, focusing on the...

Publications

Reitox national focal points’ activities during the COVID-19 pandemic

11.12.2020

This report highlights the responses taken by the EMCDDA's Reitox network of national focal points to the COVID-19 crisis and describes the challenges met by the organisations and the strategies produced to overcome these challenges.

Publications

Looking back on 25 years of annual reporting on the drugs problem in Europe

29.09.2020

In this brochure, the EMCDDA's Scientific Director takes us on a journey through 25 years of annual reporting on the drugs problem in Europe. The journey begins with the first report describing the drug situation in 1995 and leads us, over key milestones, to the latest European Drug Report 2020....

Publications

Annual accounts 2019

07.07.2020

These are the EMCDDA's final annual accounts for the financial year 2019.

Publications

General Report of Activities 2019 – key achievements and governance: a year in review

15.06.2020

The General Report of Activities is an annual publication providing a detailed progress report of the EMCDDA’s activities over a 12-month period. It catalogues the Centre’s achievements in each area of its annual work programme. The report is a useful information source for all those seeking...

Publications

Timeline: EMCDDA preparedness and response

30.04.2020

Over the past quarter of a century, the EMCDDA has expanded its monitoring capability to keep pace with revolutionary changes in the extent and nature of the drugs problem and in the world in which we live. By complementing data routinely submitted by Member States with information from an...

Publications

Timeline: 25 years of monitoring — selected events from the EMCDDA’s international cooperation history

30.03.2020

Follow the timeline and take a walk through some of the key moments in the EMCDDA's 25 years of international cooperation.

Publications

Timeline: 25 years of monitoring — selected events from the EMCDDA’s history

28.02.2020

Take a journey through some of the key moments in the EMCDDA’s first quarter of a century by following the timeline and checking our main milestones.

Publications

Programming document 2020-22

24.02.2020

The Programming Document 2020-22 translates the long-term priorities defined by the EMCDDA Strategy 2025 into short-term operational priorities. The year 2020 marks the end of the first strategic roadmap and the beginning of the second one (towards 2025) and is a time for mid-term assessment and...

Publications

EMCDDA operating guidelines for the European Union Early Warning System on new psychoactive substances

19.12.2019

These guidelines provide the rationale, steps, procedures, roles, and responsibilities for the operation of the EU Early Warning System. They reflect the requirements of Regulation (EC) No 1920/2006 (as amended) and Council Framework Decision 2004/757/JHA (as amended) with respect to information...

Publications

The Reitox network: frequently asked questions

21.10.2019

This information brochure has been produced by the EMCDDA to provide answers to the most commonly asked questions on the Reitox network of national focal points and more broadly on national drugs observatories. Compiled over several years, it is a reference tool for both EU Member States and...

Publications

The EU drugs strategy: a model for common action

07.10.2019

On the basis of an external evaluation of the EU drugs strategy 2005-12, on 7 December 2012 the Justice and Home Affairs Council of the European Union endorsed a new EU drugs strategy (2013-20). The strategy was designed to be implemented by two consecutive 4-year action plans. An external...
Loading